PromarkerD Intellectual Property portfolio expands

Earlier from Proteomics International Laboratories

• Appendix 3Y - Directors on-market purchase of sharesJun 28, 2020
• Big pharma clinical study validates PromarkerD kidney testJun 14, 2020
• Updated Investor PresentationJun 9, 2020
• Proteomics International receives COVID-19 research grantsMay 25, 2020
• Appendix 4C and Quarterly Report - March 2020Apr 27, 2020

Later from Proteomics International Laboratories

• June 2020 Quarterly Activities Report and Appendix 4CJul 28, 2020
• Partnership with QIMR Berghofer targets oesophageal cancerOct 8, 2020
• First distribution agreement for PromarkerD immunoassayOct 15, 2020
• Proteomics International raises $6m in successful PlacementOct 22, 2020
• September 2020 Quarterly Activities Report and Appendix 4COct 27, 2020